Infusion Pumps Market Improvement in healthcare facilities 2025

Global Infusion Pumps Market: Snapshot

Infusion pumps are devices that permeate nutrients, fluids, or medications into the circulatory system of a patient’s body. In general, it is used intravenously in most of the cases. However, epidural, subcutaneous, and arterial infusions are also being used in quite a few cases. The credit of the infusion pumps go to the way these pumps can administer fluids. It is not all feasible and expensive for a trained nurse to administer medication, nutrients, or fluids into a patient’s body in a way that infusion pump does.

For instance, infusion pumps can infuse as little as 0.1 mL per hour injection or injection with repeated boluses or an injection per minute as per the requests made by the patient. It can give injections up to a maximum number of times per hour, for instance, in cases of patient controlled analgesia and it can also vary the fluids as and when required by the patients. Infusion pumps are capable of creating immense pressure but at the same time they are able to control pressure as well. These pumps are used to inject regulated amount of fluids just beneath the skin or subcutaneously as it is commonly known as. Epidural is another method that is used by infusion pumps to inject fluids just in the surface of the central nervous system, for this method is implemented while administering local anesthesia to pregnant woman during childbirth.

Request Sample Copy of the Report @

https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1793

Infusion Pumps Market: Overview 

An infusion pump is a medical device designed to deliver fluids or drugs into a patient’s body in an administered and controlled manner; fluids may include nutrients or different types of medications such as insulin, hormones, pain relievers, antibiotics, and chemotherapy drugs. The devices can be powered mechanically or electrically and can be used in a variety of clinical settings.

The market has evolved rapidly driven by a steady demand for different types of infusion pumps—stationary and ambulatory infusion pumps—for the management of a wide range of ailments that include cancer, diabetes, gastrointestinal diseases, neurological disorders, and AIDS. Over the past few years, the infusion pumps market has witnessed growing popularity of various specialized types such as enteral feeding pumps, patient-controlled analgesia (PCA) pump, and insulin pumps among patients. Manufacturers of medical devices are constantly making efforts to increase the reliability and safety of infusion pumps and to reduce medication errors delivered by intravenous infusion. 

Request TOC of the Report @

https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1793

Infusion Pumps Market: Trends 

The infusion pumps market is primarily driven by the increasing incidence of various chronic diseases, the management of which requires safe and controlled administration of medications and drugs. In addition, the increasing number of surgeries performed in developed and developing regions and a rise in geriatric population are expected to fuel the market. The increasing inclination toward the adoption of alternative therapies for the treatment of cancer, multiple sclerosis, congestive pain, rheumatoid arthritis, and chronic pain has stimulated the demand for infusion pumps. For instance, the adoption of intrathecal drug delivery is emerging as a viable option for the treatment of patients suffering from chronic and intractable pain or severe spasticity.

Coupled with this, constant automation and technological advancements in infusion devices and accessories have led to the availability of smart infusion pumps with ergonomic design, enhanced operation, user-friendly interfaces, and portability, thereby propelling the market.

Read Comprehensive Overview of Report @

https://www.tmrresearch.com/infusion-pumps-market 

Infusion Pumps Market: Market Potential 

The increased adoption of insulin pumps for the self-management of diabetes across home settings and the adoption of implantable infusion systems for neurological diseases are developments expected to expand the potential of the infusion pumps market.

Flowonix Medical Inc., a pioneer in drug delivery systems company based in New Jersey, and Cerebral Therapeutics, a company based in Colorado, have announced the world’s first clinical trial administering medication directly into the brain of patients suffering from refractory epilepsy. The two companies jointly developed Prometra II Programmable Pump, an implantable infusion pump, to be used with an intrathecal catheter for the affected patients in the Australian Direct Drug Administration for Refractory Epilepsy (ADDRESS) clinical trial conducted at St. Vincent’s Hospital, Australia. The wide ranging clinical study will enable the companies to assess the efficacy of micro-infusion therapy featuring the intracerebroventricular (ICV) delivery of the drug—valproate sodium—among patients with intractable epilepsy.

The study, believes the participants will have profound ramifications in the potential of implantable infusion therapies for the treatment of drug-resistant uncontrollable epilepsy and is expected to benefit the healthcare community at large. Although the Prometra II Pump is not yet approved for the ICV administration of valproate in the U.S. and Australia, the clinical study opens up promising options.

Infusion Pumps Market: Regional Outlook 

Among major regions, North America is a prominent market for infusion pumps and is expected to exhibit impressive growth along the forecast period. The significant growth in the regional market is attributable to the rising penetration of high-end pumps, soaring adoption of ambulatory pumps for managing chronic diseases, and the presence of a robust healthcare infrastructure. In addition, the increased integration of infusion therapy in healthcare IT infrastructure has propelled the regional market.

The Asia Pacific market is anticipated to witness substantial growth along the forecast period. A rapid rise in geriatric population, increasing accessibility of healthcare facilities, advances in health insurance sector, and a rise in chronic diseases are the factors fuelling the regional market. 

Infusion Pumps Market: Competitive Analysis 

Several companies are offering technologically advanced infusion therapies, including implantable, wearable, and automated infusion pumps, to help the management of a wide range of chronic diseases. Major players operating in the infusion pumps market include B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Pfizer Inc., Medtronic, Terumo Corporation, and Roche Diagnostics.

Infusion Pumps Market is Anticipated to Surpass US$ 10,000.0 Mn by 2026

Transparency Market Research (TMR) titled “Infusion Pumps Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the new report, the global infusion pumps market was valued at approximately US$ 7,036 Mn in 2017 is projected to expand at a CAGR of more than 5.4% from 2018 to 2026.

The report suggests that the rise in geriatric population susceptible to chronic pains and increase in prevalence of diabetes globally are likely to boost demand for infusion pumps during the forecast period. North America and Europe are likely to dominate the global infusion pumps market due to increase in awareness and rise in focus of key players on the development of new drugs delivery systems in the market in these regions. Demand for low-cost infusion devices and favorable reimbursement policies for using infusion pumps in emerging markets such as Australia, India, and Japan are likely to boost the infusion pumps market in Asia Pacific at a CAGR of 5.9% from 2018 to 2026.

Infusion pumps are extensively used across the health care setting to pump fluids into patients in controlled manner. These pumps are associated with various problems. Most commonly reported problems include software error messages, battery failure, and alarm failure. These are major factors restraining the market. For example, in 2017, Smith Medical’s Medfusion Syringe Pump 4000 Series was recalled as these pumps were unable to accurately detect the diameter of the syringe barrel, resulting in initiation of the “Invalid Syringe Size” alarm.

Request to View Sample of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1601

The report offers detailed segmentation of global infusion pumps market based on product type, application, end-user, and distribution channel. Based on product type, the insulin segment is estimated to account for a large share of the global market during the forecast period. This is due to the rise in incidence of diabetes. Moreover, several studies have proved that insulin pumps are effective in both type 1 and type 2 diabetes and help reduce the rate of hospitalization after usage. The implantable segment is anticipated to lose market share during the forecast period, and is expected to account for share of about 12.2% by 2026, which is a decline from 14.5% share held in 2017. High price of these devices and complications such as pain and vomiting after implantation are factors that are likely to hamper this segment.

In terms of value, North America held a major share of the global infusion pumps market in 2017. This is due to the high health care expenditure and rise in awareness about the advantages of infusion pumps in the U.S. Furthermore, presence of several key players such as ICU MEDICAL, Inc. and Becton, Dickinson and Company has increased investment in research & development of advancement infusion pumps. Thus, presence of these players is projected to propel the infusion pumps market in North America at a rapid pace during the forecast period. Increase in incidence of age-related chronic conditions such as diabetes, cancer, and neurological illnesses increases demand for infusion pumps in Asia Pacific. Moreover, improving economic conditions, rise in spending power, and better access to health care service fuels the market in Asia Pacific. Economic growth in countries such as Brazil is increasing research & development activities and expenditure on treatment in Latin America. These factors are likely to propel the infusion pumps market in Latin America to expand at a CAGR of 4.9% from 2018 to 2026.

Infusion Pumps Market: Ability to Deliver Accurate Dosages of Drugs at Proper Intervals Stokes Uptake

San Francisco, California, December 26, 2017: A recently added market study by TMR Research, titled, “Infusion Pumps Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017–2025,” offers crucial information on the market so as to enable stakeholders in the market to take timely, informed decisions. To that end, it discusses in detail factors boosting or hampering the market and prominent trends and competitive dynamics molding its trajectory. It also sheds light on the size of the market based on current and historical figures and segments it depending on various parameters so as to understand which segments hold out most promise.

The primary function of infusion pumps is to deliver drugs or fluids such as nutrients or medications namely hormones, insulin, antibiotics, pain relievers, chemotherapy drugs, etc. in a patient’s body. It has many advantages. For instance, it can inject as little as 0.1 mL per hour or give a shot per minute as per the requirement of the patient. It can also regulate the flow of fluids – both drugs and other fluids – as and when needed. Besides, infusion pumps have the ability to generate tremendous pressure and also control the pressure as well. Infusion pumps also find application during the epidural procedure in childbirth. Owing to the aforementioned uses and benefits, infusion pumps save the cost of hiring a trained nurse to do the job of administering nutrients, medication, or fluids. As a result, their market is steadily growing.

Apart from that, the demand for infusion pumps is seeing a steady upswing on the back of increasing instances of different chronic diseases and rising number of surgeries. The growing pool of elderly is majorly contributing to the market since they are more prone of chronic diseases and often require surgeries. The increasing inclination towards alternative therapies for cancer, congestive pain, multiple sclerosis, chronic pain, and rheumatoid arthritis has stoked sales of infusion pumps.

There are various types of infusion pumps such as ambulatory and stationary infusion pumps sold in the market. They help to treat a wide array of diseases, namely diabetes, cancer, gastrointestinal diseases, AIDS, and neurological disorders. Insulin pumps, enteral feeding pumps, patient-controlled analgesia (PCA) pump, and insulin pumps are fast gaining popularity among patients. On order to up sales, manufacturers of medical devices are spending money on development of effective infusion pumps that are far more safer and administer medicines more accurately.

A noticeable trend in the market is the emergence of smart infusion pumps that leverages automation and modern sophisticated technologies such as cloud and analytics with ergonomic design, improved operation, user-friendly interfaces, and portability. The rising uptake of insulin pumps for managing diabetes by oneself in home settings and the adoption of implantable infusion systems for neurological diseases are developments that are expected to open up new avenues for growth in the market.

From a geographic perspective, North America plays a crucial role in the global market for infusion pumps. In the years ahead, the region is expected to expand at a healthy clip on the back of abundant availability of high-end pumps, swift uptake of ambulatory pumps for tackling chronic diseases, and the presence of a solid healthcare infrastructure. Asia Pacific is another key market that is predicted to clock impressive growth in the upcoming years owing to a burgeoning geriatric population, rising occurrence of chronic diseases and bettering healthcare infrastructure.

Some of the prominent participants in the global market for infusion pumps are B. Braun Melsungen AG, Becton, Dickinson and Company, Fresenius SE & Co. KGaA, Pfizer Inc., Medtronic, Roche Diagnostics, and Terumo Corporation.

Get Sample Copy of this Report

https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1793